Table 3 Pap test findings in patients
AIS (n = 19) | ADC (n = 71) | MASL (n = 135) | |||
|---|---|---|---|---|---|
Cytology | N(%) | Cytology | N(%) | Cytology | N(%) |
AGC-NOS | 1(5.26%) | AGC-NOS | 1(1.41%) | AGC-NOS | 4(2.96%) |
AGC | 3(15.79%) | AGC | 4(5.63%) | AGC | 6(4.44%) |
AGC-FN | 1(5.26%) | AGC-FN | 5(7.04%) | AGC-FN | 6(4.44%) |
ASC-US/LSIL | 4(21.05%) | AIS | 1(1.41%) | AGC + HSIL(Suspicious for SCC) | 2(1.48%) |
ASC-H/HSIL | 2(10.53%) | AGC + ASC-H | 1(1.41%) | AGC + ASC-H | 1(0.74%) |
NILM | 7(36.84%) | AGC + ASC-US | 1(1.41%) | AGC + ASC-US | 1(0.74%) |
Not done or Unknown | 1(5.26%) | ASC-US/LSIL | 10(14.08%%) | ASC-US /LSIL | 31(22.96%) |
ASC-H/ASC-H/SCC | 7(9.86%) | ASC-H/HSIL/SCC | 25(18.52%) | ||
AGC + ASC-H | 1(1.41%) | LSIL-H | 4(2.96%) | ||
Malignancy | 1(1.41%) | HSIL, Suspicious for SCC | 2(1.48%) | ||
NILM | 22(30.99%) | ADC | 2(1.48%) | ||
Not done or Unknown | 17(23.94%) | NILM | 32(23.7%) | ||
Not done or Unknown | 19(14.07%) | ||||